Skip to content
YCW23· Other

Modulari-T

We teach your immune system to attack and cure cancer

ActiveChecked 20h ago
Batch
W23
Status, per YC
Active
Team size
4
HQ
Montreal, QC
In W23274 companies, 68% AI
modularit.bioYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About Modulari-T

Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.

Montreal, QC, Canada; San Francisco, CA, USA

Modulari-T: questions

Which YC batch was Modulari-T in?

Modulari-T was in Y Combinator's Winter 2023 batch (W23).

Is Modulari-T still active?

Y Combinator lists Modulari-T as active.

Where is Modulari-T based?

Modulari-T lists Montreal, QC, Canada; San Francisco, CA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.